Industries > Pharma > Precision Cancer Diagnostic Test Market Report 2022-2032
Precision Cancer Diagnostic Test Market Report 2022-2032
Forecasts by Biopsy Method (Tissue Biopsy, Liquid Biopsy), by End-user (Hospitals, Clinics, Research Institutes), by Category (Cancer Imaging, Molecular Cancer Testing, Tumour Marker Immunoassays, POC Colon Cancer Tests, Other), by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Pancreatic Cancer, Other), by Molecular Cancer Testing (Blood-Based Molecular Cancer Tests, HPV Genotyping, Circulating Tumour Cell (CTC) Tests, Next-Generation Sequencing Tests), by Cancer Imaging Test (Computed Tomography, Magnetic Resonance Imaging, Digital & Analog Mammography, Positron Emission Tomography, Digital Breast Tomosynthesis, Molecular Breast Imaging) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios
The Precision Cancer Diagnostic Test Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Advancements in Technologies such as Functional Precision Medicine (FPM) Models
Some of the practical challenges of FPM can be addressed using new technologies created at the intersection of engineering and biology. Technology targeted at simulating the tumour microenvironment, particularly the extracellular matrix, has made significant progress. Organ chips (sometimes referred to as tissue chips or microphysiological systems) are indeed being used to depict cancer inside the tumour microenvironment. Such microfluidics devices, which are typically composed of tissue-specific types of cells, extracellular matrix gels, and cancerous cells, attempt to replicate the molecular and mechanical signals present in human tissue. One of the possible advantages of organ chips is their ability to replicate medicine distribution, pharmacokinetics, pharmacodynamics, and drug toxicity.
Some of the hurdles to the broad use of organ chips in FPM include low drug testing throughput and the necessity for specialised skills to create and operate these devices. Allowing cells to remain in their native habitat throughout pharmaceutical therapy is another way to simulate tumour settings. This comprises medication treatment on individual tumour sections or fine-needle biopsies, wherein immunofluorescent cell death signs can be used to assess drug sensitivity. Its use of drug-containing microdevices which may be implanted directly into patients’ tumours is another promising approach for FPM. The medications in such microdevices can affect surrounding tissues, and therapy results in tumours can indeed be evaluated after they’ve been removed.
What Questions Should You Ask before Buying a Market Research Report?
• How is the precision cancer diagnostic test market evolving?
• What is driving and restraining the precision cancer diagnostic test market?
• How will each precision cancer diagnostic test submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each precision cancer diagnostic test submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading precision cancer diagnostic test markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the precision cancer diagnostic test projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implication of precision cancer diagnostic test projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the precision cancer diagnostic test market?
• Where is the precision cancer diagnostic test market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the precision cancer diagnostic test market today, and over the next 10 years:
• Our 602-page report provides 347 tables and 326 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analyse of global, regional and national sales and growth
• It highlights for you the key successful trends, changes and revenue projections made by your competitors
This report tells you TODAY how the precision cancer diagnostic test market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
This report delivers exclusive COVID-19 variations and economic data specific to your market.
To access the data contained in this document please email contactus@visiongain.com
Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising precision cancer diagnostic test prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in this report
Biopsy Method
• Tissue Biopsy
• Liquid Biopsy
End-User
• Hospitals
• Clinics
• Research Institutes
Category
• Cancer Imaging
• Molecular Cancer Testing
• Tumour Marker Immunoassays
• POC Colon Cancer Tests
• Other Categories
Cancer Type
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Pancreatic Cancer
• Other Cancer Type
Cancer Testing
• Blood-Based Molecular Cancer Tests
• HPV Genotyping
• Circulating Tumour Cell (CTC) Tests
• Next-Generation Sequencing Tests
Imaging Test
• Computed Tomography
• Magnetic Resonance Imaging
• Digital & Analog Mammography
• Positron Emission Tomography
• Digital Breast Tomosynthesis
• Molecular Breast Imaging
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
• U.S.
• Canada
• Mexico
Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
LAMEA
• Brazil
• Turkey
• Saudi Arabia
• South Africa
• UAE
• Rest of Latin America, Middle East and Africa
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Precision Cancer Diagnostic Test Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Abbott Laboratories (Abbott)
• Agilent Technologies, Inc.
• AstraZeneca PLC (AstraZeneca)
• Becton, Dickinson and Firm (BD)
• Biocept, Inc.
• Bio-Rad Laboratories Inc.
• Epigenomics AG
• Illumina, Inc. (Illumina)
• Myriad Genetics, Inc. (Myriad)
• Quest Diagnostics Incorporated
Overall world revenue for Precision Cancer Diagnostic Test Market, 2022 to 2032 in terms of value the market will surpass US$15,834 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Precision Cancer Diagnostic Test Market, 2022 to 2032 Market report help you?
In summary, our 602-page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Precision Cancer Diagnostic Test Market, 2022 to 2032 Market, with forecasts for biopsy method, end-user, cancer type, category, molecular cancer testing each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Precision Cancer Diagnostic Test Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Precision Cancer Diagnostic Test Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analysis for the Precision Cancer Diagnostic Test Market, 2022 to 2032 and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Precision Cancer Diagnostic Test Market Report 2022-2032: Forecasts by Biopsy Method (Tissue Biopsy, Liquid Biopsy), by End-user (Hospitals, Clinics, Research Institutes), by Category (Cancer Imaging, Molecular Cancer Testing, Tumour Marker Immunoassays, POC Colon Cancer Tests, Other), by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Pancreatic Cancer, Other), by Molecular Cancer Testing (Blood-Based Molecular Cancer Tests, HPV Genotyping, Circulating Tumour Cell (CTC) Tests, Next-Generation Sequencing Tests), by Cancer Imaging Test (Computed Tomography, Magnetic Resonance Imaging, Digital & Analog Mammography, Positron Emission Tomography, Digital Breast Tomosynthesis, Molecular Breast Imaging) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview
1.1 Introduction to Precision Cancer Diagnostic Test Market
1.2 Global Precision Cancer Diagnostic Test Market Overview
1.3 What Are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Precision Cancer Diagnostic Test Market Definition
1.6 Why You Should Read this Report
1.7 What this Report Delivers
1.8 Key Questions Answered by this Analytical Report Include:
1.9 Who is this Report for?
1.10 Research Methodology
1.10.1 Primary Research
1.10.2 Secondary Research
1.10.3 Market Evaluation & Forecasting Methodology
1.11 Frequently Asked Questions (FAQs)
1.12 Associated Visiongain Reports
1.13 About Visiongain
2 Executive Summary
3 Global Market Dynamics
3.1 Market Driving Factors
3.1.1 Emerging FPM Models and Technologies
3.1.2 NGS Technologies Are Rapidly Being Used in Place of Traditional Approaches
3.1.3 Precision Cancer Medicine's Expanding Breadth
3.2 Market Restraining Factors
3.2.1 Disadvantages and Limitations of Precision Medicine in Cancer
3.2.2 Cost of Cancer Precision Medicine
3.2.3 Difficulty of Converting Basic Genetic Data into Clinically Relevant and Effective Conclusions
3.3 Opportunities in the Global Market
3.3.1 Enhanced Trial Opportunities
3.3.2 Number of Companion Molecular Diagnostic Assays Approved by the FDA is Increasing
3.3.3 Integration of Diagnostic and Treatment Data with Emerging Artificial Intelligence/Machine Learning Platforms
3.3.4 CDx Can Play an Important Function
3.4 Challenges in the Global Market
3.4.1 Expense of Testing for Genetic Changes and Subsequent Targeted Therapy
3.4.2 Precision Medicine's Incorporation into Clinical Oncology Operations Has Been Delayed
3.4.3 Technical Difficulties Related with the Development of Precision Medicine’s Evidence
3.5 SWOT Analysis
3.6 PEST Analysis
3.6.1 Political
3.6.2 Economical
3.6.3 Social
3.6.4 Technological
3.7 Porters Analysis
3.7.1 Competitive Rivalry
3.7.2 Bargaining Power of Suppliers
3.7.3 Bargaining Power of Customers
3.7.4 Threat of New Entrants
3.7.5 Threat of Substitutes
4 Global Precision Cancer Diagnostic Test Market Analysis
4.1 Global Market Outlook
4.2 Global Market Size Estimation and Forecast
4.2.1 Pre-COVID-19 Market Scenario
4.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5 Global Precision Cancer Diagnostic Test Market Analysis by Region
5.1 North America
5.2 Europe
5.3 Asia-Pacific
5.4 LAMEA
5.5 Regional Market Size Estimation and Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Market Size Estimation and Forecast by Biopsy Method
6.1 Tissue Biopsy
6.2 Liquid Biopsy
6.3 Pre-COVID-19 Market Scenario
6.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Market Size Estimation and Forecast by End-User
7.1 Hospitals
7.2 Clinics
7.3 Research Institutes
7.4 Pre-COVID-19 Market Scenario
7.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Market Size Estimation and Forecast by Category
8.1 Cancer Imaging
8.2 Molecular Cancer Testing
8.3 Tumour Marker Immunoassays
8.4 POC Colon Cancer Tests
8.5 Others
8.6 Pre-COVID-19 Market Scenario
8.7 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 Global Market Size Estimation and Forecast by Cancer Type
9.1 Breast Cancer
9.2 Lung Cancer
9.3 Colorectal Cancer
9.4 Melanoma
9.5 Pancreatic Cancer
9.6 Other Cancer Types
9.7 Pre-COVID-19 Market Scenario
9.8 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 Global Market Size Estimation and Forecast by Molecular Cancer Testing
10.1 Blood-Based Molecular Cancer Tests
10.2 HPV Genotyping
10.3 Circulating Tumour Cell (CTC) Tests
10.4 Next-Generation Sequencing Tests
10.5 Pre-COVID-19 Market Scenario
10.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 Global Market Size Estimation and Forecast by Cancer Imaging Test
11.1 Computed Tomography
11.2 Magnetic Resonance Imaging
11.3 Digital & Analog Mammography
11.4 Positron Emission Tomography
11.5 Digital Breast Tomosynthesis
11.6 Molecular Breast Imaging
11.7 Pre-COVID-19 Market Scenario
11.8 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 North America Market Size Estimation and Forecast
12.1 Market Outlook
12.2 North America Market Size Estimation and Forecast
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Country Market Size Estimation and Forecast
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 North America Market Size Estimation and Forecast by Biopsy Method
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 North America Market Size Estimation and Forecast by End-User
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 North America Market Size Estimation and Forecast by Category
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 North America Market Size Estimation and Forecast by Cancer Type
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 North America Market Size Estimation and Forecast by Molecular Cancer Testing
12.8.1 Pre-COVID-19 Market Scenario
12.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 North America Market Size Estimation and Forecast by Cancer Imaging Test
12.9.1 Pre-COVID-19 Market Scenario
12.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 US Precision Cancer Diagnostic Test Market Analysis
12.10.1 Increasing Number of Precision Medicine Clinical Trials in the United States
12.10.2 Pre-COVID-19 Market Scenario
12.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 Canada Precision Cancer Diagnostic Test Market Analysis
12.11.1 Adoption of New Systemic Cancer Medicines in Canada is a Multi-Step Process
12.11.2 The Use of Precision Medicine in Canada Will Aid in the Control of Cancer
12.11.3 Pre-COVID-19 Market Scenario
12.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 Mexico Precision Cancer Diagnostic Test Market Analysis
12.12.1 Developing Successful and Long-Term Precision Oncology Programmes in Mexico in Collaboration with Government Authorities and Institutions
12.12.2 Pre-COVID-19 Market Scenario
12.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 Europe Market Size Estimation and Forecast
13.1 Market Outlook
13.2 Europe Market Size Estimation and Forecast
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 Country Market Size Estimation and Forecast
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Europe Market Size Estimation and Forecast by Biopsy Method
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Europe Market Size Estimation and Forecast by End-User
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Europe Market Size Estimation and Forecast by Category
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Europe Market Size Estimation and Forecast by Cancer Type
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Europe Market Size Estimation and Forecast by Molecular Cancer Testing
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Europe Market Size Estimation and Forecast by Cancer Imaging Test
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 Germany Precision Cancer Diagnostic Test Market Analysis
13.10.1 Rapid Integration of Interdisciplinary Techniques in Germany
13.10.2 Pre-COVID-19 Market Scenario
13.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 UK Precision Cancer Diagnostic Test Market Analysis
13.11.1 Expanding Clinical Trails Studies in UK
13.11.2 Investment in Pancreatic Cancer Research
13.11.3 Pre-COVID-19 Market Scenario
13.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 France Precision Cancer Diagnostic Test Market Analysis
13.12.1 Pre-COVID-19 Market Scenario
13.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 Italy Precision Cancer Diagnostic Test Market Analysis
13.13.1 The Expansion of Precision Oncology in Italy Has Been Impeded by a Lack of Guidelines
13.13.2 Pre-COVID-19 Market Scenario
13.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Spain Precision Cancer Diagnostic Test Market Analysis
13.14.1 Precision Cancer Diagnostic Test Research is Now Focusing on Detecting a Far Larger Number of Mutations in Spain
13.14.2 Pre-COVID-19 Market Scenario
13.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.15 Rest of Europe Precision Cancer Diagnostic Test Market Analysis
13.15.1 Pre-COVID-19 Market Scenario
13.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14 Asia-Pacific Market Size Estimation and Forecast
14.1 Market Outlook
14.2 Asia-Pacific Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Country Market Size Estimation and Forecast
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 Asia-Pacific Market Size Estimation and Forecast by Biopsy Method
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 Asia-Pacific Market Size Estimation and Forecast by End-User
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 Asia-Pacific Market Size Estimation and Forecast by Category
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 Asia-Pacific Market Size Estimation and Forecast by Cancer Type
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 Asia-Pacific Market Size Estimation and Forecast by Molecular Cancer Testing
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 Asia-Pacific Market Size Estimation and Forecast by Cancer Imaging Test
14.9.1 Pre-COVID-19 Market Scenario
14.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 China Precision Cancer Diagnostic Test Market Analysis
14.10.1 Large-Scale Deployment of Self-Powered Triboelectric Nanogenerator (TENG) Devices Has Promise for Cancer Treatment
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 India Precision Cancer Diagnostic Test Market Analysis
14.11.1 Pre-COVID-19 Market Scenario
14.11.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Japan Precision Cancer Diagnostic Test Market Analysis
14.12.1 Precision Oncology Is Revolutionising Cancer Patient Treatment in Japan, but Many Hospitals Are Having Trouble Putting it into Practise
14.12.2 Pre-COVID-19 Market Scenario
14.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 South Korea Precision Cancer Diagnostic Test Market Analysis
14.13.1 Various Precision Medicine Collaborations Are Taking Place in South Korea
14.13.2 Pre-COVID-19 Market Scenario
14.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Australia Precision Cancer Diagnostic Test Market Analysis
14.14.1 Pre-COVID-19 Market Scenario
14.14.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.15 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market Analysis
14.15.1 Pre-COVID-19 Market Scenario
14.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15 LAMEA Market Size Estimation and Forecast
15.1 Market Outlook
15.2 LAMEA Market Size Estimation and Forecast
15.2.1 Pre-COVID-19 Market Scenario
15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.3 Country Market Size Estimation and Forecast
15.3.1 Pre-COVID-19 Market Scenario
15.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.4 LAMEA Market Size Estimation and Forecast by Biopsy Method
15.4.1 Pre-COVID-19 Market Scenario
15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.5 LAMEA Market Size Estimation and Forecast by End-User
15.5.1 Pre-COVID-19 Market Scenario
15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.6 LAMEA Market Size Estimation and Forecast by Category
15.6.1 Pre-COVID-19 Market Scenario
15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.7 LAMEA Market Size Estimation and Forecast by Cancer Type
15.7.1 Pre-COVID-19 Market Scenario
15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.8 LAMEA Market Size Estimation and Forecast by Molecular Cancer Testing
15.8.1 Pre-COVID-19 Market Scenario
15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.9 LAMEA Market Size Estimation and Forecast by Cancer Imaging Test
15.9.1 Pre-COVID-19 Market Scenario
15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.10 Brazil Precision Cancer Diagnostic Test Market Analysis
15.10.1 Brazil is Making Significant Contributions to Cancer Research
15.10.2 Brazil Can Easily Become a Model for Other Latin American Countries, in Terms of the Potential Benefits of Precision Medicine
15.10.3 Pre-COVID-19 Market Scenario
15.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.11 South Africa Precision Cancer Diagnostic Test Market Analysis
15.11.1 To Develop Precision Medicine Requires More Specialised Professionals in South Africa
15.11.2 Pre-COVID-19 Market Scenario
15.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.12 Saudi Arabia Precision Cancer Diagnostic Test Market Analysis
15.12.1 Precision Cancer Diagnostic Test Has Significantly Revolutionised the Cancer Diagnostic and Treatment Environment in Saudi Arabia
15.12.2 Pre-COVID-19 Market Scenario
15.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.13 Turkey Precision Cancer Diagnostic Test Market Analysis
15.13.1 Pre-COVID-19 Market Scenario
15.13.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.14 UAE Precision Cancer Diagnostic Test Market Analysis
15.14.1 Companies in the UAE Utilising New Collaboration Strategies to Increase Precision Cancer Diagnostic Test
15.14.2 Pre-COVID-19 Market Scenario
15.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.15 Rest of LAMEA Precision Cancer Diagnostic Test Market Analysis
15.15.1 Pre-COVID-19 Market Scenario
15.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16 Company Profiles
16.1 Bio-Rad Laboratories Inc.
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Financial Profile
16.1.4 Company Product Benchmarking
16.1.5 Company Recent Developments
16.2 Illumina Inc
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financial Profile
16.2.4 Company Product Benchmarking
16.2.5 Company Recent Developments
16.3 Biocept Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financial Profile
16.3.4 Company Product Benchmarking
16.3.5 Company Recent Developments
16.4 Epigenomics AG
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Financial Profile
16.4.4 Company Product Benchmarking
16.5 AstraZeneca plc
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Financial Profile
16.5.4 Company Product Benchmarking
16.5.5 Company Recent Developments
16.6 Myriad Genetics Inc.
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Product Benchmarking
16.6.4 Company Recent Developments
16.7 Quest Diagnostics Inc.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Financial Profile
16.7.4 Company Product Benchmarking
16.7.5 Company Recent Developments
16.8 Abbott Laboratories
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Financial Profile
16.8.4 Company Product Benchmarking
16.8.5 Company Recent Developments
16.9 Agilent Technologies Inc.
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Financial Profile
16.9.4 Company Product Benchmarking
16.9.5 Company Recent Developments
16.10 Becton Dickinson and Co.
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Financial Profile
16.10.4 Company Product Benchmarking
16.10.5 Company Recent Developments
17 Conclusion and Recommendations
17.1 Conclusion Summary
17.2 Recommendations
List of Figures
Figure 1 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 2 Global Precision Cancer Diagnostic Test Market Segmentation
Figure 3 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 4 SWOT Analysis
Figure 5 PEST Analysis
Figure 6 Porters Five Forces
Figure 7 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 8 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 9 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 10 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 11 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 12 Global Precision Cancer Diagnostic Test Market Share Forecast by Region 2022, 2027, 2032 (%)
Figure 13 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%))
Figure 14 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 15 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 16 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 17 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 18 Global Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method 2022, 2027, 2032 (%)
Figure 19 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 20 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 21 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 22 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 23 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 24 Global Precision Cancer Diagnostic Test Market Share Forecast by End-User 2022, 2027, 2032 (%)
Figure 25 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 26 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 27 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 28 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 29 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 30 Global Precision Cancer Diagnostic Test Market Share Forecast by Category 2022, 2027, 2032 (%)
Figure 31 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 32 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 33 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 34 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 35 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 36 Global Precision Cancer Diagnostic Test Market Share Forecast by Cancer Type 2022, 2027, 2032 (%)
Figure 37 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 38 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 39 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 40 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 41 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 42 Global Precision Cancer Diagnostic Test Market Share Forecast by Molecular Cancer Testing 2022, 2027, 2032 (%)
Figure 43 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 44 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 45 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 46 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 47 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 48 Global Precision Cancer Diagnostic Test Market Share Forecast by Cancer Imaging Test 2022, 2027, 2032 (%)
Figure 49 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 50 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 51 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 52 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 53 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 54 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 55 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 56 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 57 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 58 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 59 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%))
Figure 60 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (V-Shaped Recovery Scenario)
Figure 61 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (W-Shaped Recovery Scenario)
Figure 62 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (U-Shaped Recovery Scenario)
Figure 63 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (L-Shaped Recovery Scenario)
Figure 64 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 65 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 66 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 67 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 68 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 69 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 70 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 71 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 72 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 73 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 74 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 75 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 76 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 77 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 78 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 79 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 80 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 81 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 82 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 83 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 84 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 85 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 86 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 87 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 88 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 89 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 90 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 91 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 92 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 93 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 94 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 95 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 96 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 97 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 98 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 99 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 100 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 101 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 102 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 103 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 104 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 105 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 106 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 107 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 108 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 109 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 110 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 111 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 112 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 113 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 114 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 115 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 116 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 117 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 118 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 119 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 120 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 121 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 122 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 123 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 124 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 125 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 126 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 127 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 128 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 129 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 130 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 131 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 132 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 133 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 134 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 135 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 136 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 137 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 138 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 139 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 140 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 141 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 142 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 143 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 144 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 145 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 146 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 147 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 148 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 149 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 150 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 151 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 152 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 153 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 154 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 155 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 156 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 157 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 158 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 159 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 160 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 161 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 162 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 163 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 164 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 165 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 166 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 167 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 168 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 169 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 170 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 171 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 172 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 173 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 174 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 175 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 176 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 177 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 178 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 179 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 180 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 181 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 182 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 183 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 184 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 185 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 186 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 187 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 188 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 189 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 190 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 191 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 192 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 193 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 194 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 195 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 196 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 197 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 198 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 199 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 200 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 201 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 202 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 203 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 204 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 205 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 206 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 207 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 208 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 209 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 210 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 211 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 212 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 213 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 214 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 215 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 216 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 217 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 218 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 219 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 220 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 221 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 222 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 223 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 224 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 225 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 226 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 227 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 228 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 229 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 230 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 231 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 232 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 233 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 234 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 235 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 236 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 237 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 238 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 239 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 240 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 241 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 242 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 243 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 244 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 245 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 246 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 247 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 248 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 249 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 250 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 251 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 252 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 253 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 254 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 255 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 256 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 257 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 258 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 259 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 260 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 261 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 262 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 263 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 264 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 265 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 266 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 267 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 268 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 269 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 270 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 271 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 272 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 273 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 274 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 275 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 276 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 277 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 278 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 279 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 280 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 281 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 282 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 283 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 284 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 285 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 286 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 287 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 288 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 289 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 290 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 291 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 292 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 293 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 294 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 295 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 296 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 297 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 298 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 299 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 300 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 301 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 302 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 303 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 304 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 305 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 306 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 307 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 308 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 309 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 310 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 311 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 312 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 313 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 314 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 315 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 316 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 317 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 318 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 319 Bio-Rad Laboratories Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 320 Bio-Rad Laboratories Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 321 Bio-Rad Laboratories Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 322 Illumina Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 323 Illumina Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 324 Illumina Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 325 Biocept Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 326 Biocept Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 327 Biocept Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 328 Epigenomics AG: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 329 Epigenomics AG: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 330 Epigenomics AG: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 331 AstraZeneca Plc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 332 AstraZeneca Plc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 333 AstraZeneca Plc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 334 Quest Diagnostics Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 335 Quest Diagnostics Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 336 Abbott Laboratories: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 337 Abbott Laboratories: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 338 Abbott Laboratories: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 339 Agilent Technologies Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 340 Agilent Technologies Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 341 Agilent Technologies Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 342 Becton Dickinson and Co: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 343 Becton Dickinson and Co: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 344 Becton Dickinson and Co: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
List of Tables
Table 1 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 2 Global Precision Cancer Diagnostic Test Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 3 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 4 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 5 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 6 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 7 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 8 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 9 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 10 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 11 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 12 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 13 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 14 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 15 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 16 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 17 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 18 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 19 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 20 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 21 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 22 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 23 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 24 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 25 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 26 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 27 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 28 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 29 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 30 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 31 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 32 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 33 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 34 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 35 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 36 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 37 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 38 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 39 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 40 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 41 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 42 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 43 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 44 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 45 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 46 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 47 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 48 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 49 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 50 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 51 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 52 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 53 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 54 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 55 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 56 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 57 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 58 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 59 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 60 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 61 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 62 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 63 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 64 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 65 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 66 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 67 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 68 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 69 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 70 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 71 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 72 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 73 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 74 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 75 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 76 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 77 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 78 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 79 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 80 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 81 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 82 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 83 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 84 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 85 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 86 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 87 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 88 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 89 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 90 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 91 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 92 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 93 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 94 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 95 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 96 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 97 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 98 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 99 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 100 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 101 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 102 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 103 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 104 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 105 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 106 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 107 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 108 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 109 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 110 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 111 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 112 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 113 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 114 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 115 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 116 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 117 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 118 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 119 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 120 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 121 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 122 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 123 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 124 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 125 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 126 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 127 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 128 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 129 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 130 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 131 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 132 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 133 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 134 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 135 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 136 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 137 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 138 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 139 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 140 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 141 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 142 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 143 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 144 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 145 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 146 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 147 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 148 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 149 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 150 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 151 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 152 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 153 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 154 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 155 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 156 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 157 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 158 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 159 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 160 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 161 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 162 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 163 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 164 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 165 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 166 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 167 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 168 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 169 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 170 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 171 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 172 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 173 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 174 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 175 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 176 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 177 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 178 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 179 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 180 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 181 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 182 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 183 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 184 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 185 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 186 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 187 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 188 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 189 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 190 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 191 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 192 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 193 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 194 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 195 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 196 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 197 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 198 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 199 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 200 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 201 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 202 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 203 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 204 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 205 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 206 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 207 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 208 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 209 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 210 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 211 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 212 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 213 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 214 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 215 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 216 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 217 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 218 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 219 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 220 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 221 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 222 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 223 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 224 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 225 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 226 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 227 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 228 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 229 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 230 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 231 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 232 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 233 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 234 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 235 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 236 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 237 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 238 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 239 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 240 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 241 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 242 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))) (L-Shaped Recovery Scenario)
Table 243 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 244 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 245 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 246 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 247 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 248 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 249 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 250 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 251 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 252 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 253 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 254 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 255 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 256 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 257 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 258 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 259 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 260 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 261 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 262 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 263 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 264 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 265 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 266 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 267 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 268 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 269 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 270 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 271 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 272 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 273 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 274 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 275 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 276 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 277 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 278 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 279 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 280 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 281 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 282 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 283 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 284 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 285 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 286 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 287 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 288 Bio-Rad Laboratories Inc.: Company Information
Table 289 Bio-Rad Laboratories Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 290 Bio-Rad Laboratories Inc.: Company Product and Service Benchmarking
Table 291 Bio-Rad Laboratories Inc: Company Recent Developments
Table 292 Illumina Inc.: Company Information
Table 293 Illumina Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 294 Illumina Inc.: Company Product and Service Benchmarking
Table 295 Illumina Inc: Company Recent Developments
Table 296 Biocept Inc.: Company Information
Table 297 Biocept Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 298 Biocept Inc.: Company Product and Service Benchmarking
Table 299 Biocept Inc: Company Recent Developments
Table 300 Epigenomics A.: Company Information
Table 301 Epigenomics AG: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 302 Epigenomics AG.: Company Product and Service Benchmarking
Table 303 AstraZeneca Plc.: Company Information
Table 304 AstraZeneca Plc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 305 AstraZeneca Plc.: Company Product and Service Benchmarking
Table 306 AstraZeneca Plc: Company Recent Developments
Table 307 Myriad Genetics Inc.: Company Information
Table 308 Myriad Genetics Inc.: Company Product and Service Benchmarking
Table 309 Myriad Genetics Inc: Company Recent Developments
Table 310 Quest Diagnostics Inc.: Company Information
Table 311 Quest Diagnostics Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 312 Quest Diagnostics Inc.: Company Product and Service Benchmarking
Table 313 Quest Diagnostics Inc: Company Recent Developments
Table 314 Abbott Laboratories.: Company Information
Table 315 Abbott Laboratories: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 316 Abbott Laboratories.: Company Product and Service Benchmarking
Table 317 Abbott Laboratories: Company Recent Developments
Table 318 Agilent Technologies Inc.: Company Information
Table 319 Agilent Technologies Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 320 Agilent Technologies Inc: Company Product and Service Benchmarking
Table 321 Agilent Technologies Inc: Company Recent Developments
Table 322 Becton Dickinson and Co.: Company Information
Table 323 Becton Dickinson and Co: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 324 Becton Dickinson and Co.: Company Product and Service Benchmarking
Table 325 Becton Dickinson and Co: Company Recent Developments
1.1 Introduction to Precision Cancer Diagnostic Test Market
1.2 Global Precision Cancer Diagnostic Test Market Overview
1.3 What Are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Precision Cancer Diagnostic Test Market Definition
1.6 Why You Should Read this Report
1.7 What this Report Delivers
1.8 Key Questions Answered by this Analytical Report Include:
1.9 Who is this Report for?
1.10 Research Methodology
1.10.1 Primary Research
1.10.2 Secondary Research
1.10.3 Market Evaluation & Forecasting Methodology
1.11 Frequently Asked Questions (FAQs)
1.12 Associated Visiongain Reports
1.13 About Visiongain
2 Executive Summary
3 Global Market Dynamics
3.1 Market Driving Factors
3.1.1 Emerging FPM Models and Technologies
3.1.2 NGS Technologies Are Rapidly Being Used in Place of Traditional Approaches
3.1.3 Precision Cancer Medicine's Expanding Breadth
3.2 Market Restraining Factors
3.2.1 Disadvantages and Limitations of Precision Medicine in Cancer
3.2.2 Cost of Cancer Precision Medicine
3.2.3 Difficulty of Converting Basic Genetic Data into Clinically Relevant and Effective Conclusions
3.3 Opportunities in the Global Market
3.3.1 Enhanced Trial Opportunities
3.3.2 Number of Companion Molecular Diagnostic Assays Approved by the FDA is Increasing
3.3.3 Integration of Diagnostic and Treatment Data with Emerging Artificial Intelligence/Machine Learning Platforms
3.3.4 CDx Can Play an Important Function
3.4 Challenges in the Global Market
3.4.1 Expense of Testing for Genetic Changes and Subsequent Targeted Therapy
3.4.2 Precision Medicine's Incorporation into Clinical Oncology Operations Has Been Delayed
3.4.3 Technical Difficulties Related with the Development of Precision Medicine’s Evidence
3.5 SWOT Analysis
3.6 PEST Analysis
3.6.1 Political
3.6.2 Economical
3.6.3 Social
3.6.4 Technological
3.7 Porters Analysis
3.7.1 Competitive Rivalry
3.7.2 Bargaining Power of Suppliers
3.7.3 Bargaining Power of Customers
3.7.4 Threat of New Entrants
3.7.5 Threat of Substitutes
4 Global Precision Cancer Diagnostic Test Market Analysis
4.1 Global Market Outlook
4.2 Global Market Size Estimation and Forecast
4.2.1 Pre-COVID-19 Market Scenario
4.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5 Global Precision Cancer Diagnostic Test Market Analysis by Region
5.1 North America
5.2 Europe
5.3 Asia-Pacific
5.4 LAMEA
5.5 Regional Market Size Estimation and Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Market Size Estimation and Forecast by Biopsy Method
6.1 Tissue Biopsy
6.2 Liquid Biopsy
6.3 Pre-COVID-19 Market Scenario
6.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Market Size Estimation and Forecast by End-User
7.1 Hospitals
7.2 Clinics
7.3 Research Institutes
7.4 Pre-COVID-19 Market Scenario
7.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Market Size Estimation and Forecast by Category
8.1 Cancer Imaging
8.2 Molecular Cancer Testing
8.3 Tumour Marker Immunoassays
8.4 POC Colon Cancer Tests
8.5 Others
8.6 Pre-COVID-19 Market Scenario
8.7 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 Global Market Size Estimation and Forecast by Cancer Type
9.1 Breast Cancer
9.2 Lung Cancer
9.3 Colorectal Cancer
9.4 Melanoma
9.5 Pancreatic Cancer
9.6 Other Cancer Types
9.7 Pre-COVID-19 Market Scenario
9.8 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 Global Market Size Estimation and Forecast by Molecular Cancer Testing
10.1 Blood-Based Molecular Cancer Tests
10.2 HPV Genotyping
10.3 Circulating Tumour Cell (CTC) Tests
10.4 Next-Generation Sequencing Tests
10.5 Pre-COVID-19 Market Scenario
10.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 Global Market Size Estimation and Forecast by Cancer Imaging Test
11.1 Computed Tomography
11.2 Magnetic Resonance Imaging
11.3 Digital & Analog Mammography
11.4 Positron Emission Tomography
11.5 Digital Breast Tomosynthesis
11.6 Molecular Breast Imaging
11.7 Pre-COVID-19 Market Scenario
11.8 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 North America Market Size Estimation and Forecast
12.1 Market Outlook
12.2 North America Market Size Estimation and Forecast
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Country Market Size Estimation and Forecast
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 North America Market Size Estimation and Forecast by Biopsy Method
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 North America Market Size Estimation and Forecast by End-User
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 North America Market Size Estimation and Forecast by Category
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 North America Market Size Estimation and Forecast by Cancer Type
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 North America Market Size Estimation and Forecast by Molecular Cancer Testing
12.8.1 Pre-COVID-19 Market Scenario
12.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 North America Market Size Estimation and Forecast by Cancer Imaging Test
12.9.1 Pre-COVID-19 Market Scenario
12.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 US Precision Cancer Diagnostic Test Market Analysis
12.10.1 Increasing Number of Precision Medicine Clinical Trials in the United States
12.10.2 Pre-COVID-19 Market Scenario
12.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 Canada Precision Cancer Diagnostic Test Market Analysis
12.11.1 Adoption of New Systemic Cancer Medicines in Canada is a Multi-Step Process
12.11.2 The Use of Precision Medicine in Canada Will Aid in the Control of Cancer
12.11.3 Pre-COVID-19 Market Scenario
12.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 Mexico Precision Cancer Diagnostic Test Market Analysis
12.12.1 Developing Successful and Long-Term Precision Oncology Programmes in Mexico in Collaboration with Government Authorities and Institutions
12.12.2 Pre-COVID-19 Market Scenario
12.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 Europe Market Size Estimation and Forecast
13.1 Market Outlook
13.2 Europe Market Size Estimation and Forecast
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 Country Market Size Estimation and Forecast
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Europe Market Size Estimation and Forecast by Biopsy Method
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Europe Market Size Estimation and Forecast by End-User
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Europe Market Size Estimation and Forecast by Category
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Europe Market Size Estimation and Forecast by Cancer Type
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Europe Market Size Estimation and Forecast by Molecular Cancer Testing
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Europe Market Size Estimation and Forecast by Cancer Imaging Test
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 Germany Precision Cancer Diagnostic Test Market Analysis
13.10.1 Rapid Integration of Interdisciplinary Techniques in Germany
13.10.2 Pre-COVID-19 Market Scenario
13.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 UK Precision Cancer Diagnostic Test Market Analysis
13.11.1 Expanding Clinical Trails Studies in UK
13.11.2 Investment in Pancreatic Cancer Research
13.11.3 Pre-COVID-19 Market Scenario
13.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 France Precision Cancer Diagnostic Test Market Analysis
13.12.1 Pre-COVID-19 Market Scenario
13.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 Italy Precision Cancer Diagnostic Test Market Analysis
13.13.1 The Expansion of Precision Oncology in Italy Has Been Impeded by a Lack of Guidelines
13.13.2 Pre-COVID-19 Market Scenario
13.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Spain Precision Cancer Diagnostic Test Market Analysis
13.14.1 Precision Cancer Diagnostic Test Research is Now Focusing on Detecting a Far Larger Number of Mutations in Spain
13.14.2 Pre-COVID-19 Market Scenario
13.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.15 Rest of Europe Precision Cancer Diagnostic Test Market Analysis
13.15.1 Pre-COVID-19 Market Scenario
13.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14 Asia-Pacific Market Size Estimation and Forecast
14.1 Market Outlook
14.2 Asia-Pacific Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Country Market Size Estimation and Forecast
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 Asia-Pacific Market Size Estimation and Forecast by Biopsy Method
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 Asia-Pacific Market Size Estimation and Forecast by End-User
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 Asia-Pacific Market Size Estimation and Forecast by Category
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 Asia-Pacific Market Size Estimation and Forecast by Cancer Type
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 Asia-Pacific Market Size Estimation and Forecast by Molecular Cancer Testing
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 Asia-Pacific Market Size Estimation and Forecast by Cancer Imaging Test
14.9.1 Pre-COVID-19 Market Scenario
14.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 China Precision Cancer Diagnostic Test Market Analysis
14.10.1 Large-Scale Deployment of Self-Powered Triboelectric Nanogenerator (TENG) Devices Has Promise for Cancer Treatment
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 India Precision Cancer Diagnostic Test Market Analysis
14.11.1 Pre-COVID-19 Market Scenario
14.11.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Japan Precision Cancer Diagnostic Test Market Analysis
14.12.1 Precision Oncology Is Revolutionising Cancer Patient Treatment in Japan, but Many Hospitals Are Having Trouble Putting it into Practise
14.12.2 Pre-COVID-19 Market Scenario
14.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 South Korea Precision Cancer Diagnostic Test Market Analysis
14.13.1 Various Precision Medicine Collaborations Are Taking Place in South Korea
14.13.2 Pre-COVID-19 Market Scenario
14.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Australia Precision Cancer Diagnostic Test Market Analysis
14.14.1 Pre-COVID-19 Market Scenario
14.14.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.15 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market Analysis
14.15.1 Pre-COVID-19 Market Scenario
14.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15 LAMEA Market Size Estimation and Forecast
15.1 Market Outlook
15.2 LAMEA Market Size Estimation and Forecast
15.2.1 Pre-COVID-19 Market Scenario
15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.3 Country Market Size Estimation and Forecast
15.3.1 Pre-COVID-19 Market Scenario
15.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.4 LAMEA Market Size Estimation and Forecast by Biopsy Method
15.4.1 Pre-COVID-19 Market Scenario
15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.5 LAMEA Market Size Estimation and Forecast by End-User
15.5.1 Pre-COVID-19 Market Scenario
15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.6 LAMEA Market Size Estimation and Forecast by Category
15.6.1 Pre-COVID-19 Market Scenario
15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.7 LAMEA Market Size Estimation and Forecast by Cancer Type
15.7.1 Pre-COVID-19 Market Scenario
15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.8 LAMEA Market Size Estimation and Forecast by Molecular Cancer Testing
15.8.1 Pre-COVID-19 Market Scenario
15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.9 LAMEA Market Size Estimation and Forecast by Cancer Imaging Test
15.9.1 Pre-COVID-19 Market Scenario
15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.10 Brazil Precision Cancer Diagnostic Test Market Analysis
15.10.1 Brazil is Making Significant Contributions to Cancer Research
15.10.2 Brazil Can Easily Become a Model for Other Latin American Countries, in Terms of the Potential Benefits of Precision Medicine
15.10.3 Pre-COVID-19 Market Scenario
15.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.11 South Africa Precision Cancer Diagnostic Test Market Analysis
15.11.1 To Develop Precision Medicine Requires More Specialised Professionals in South Africa
15.11.2 Pre-COVID-19 Market Scenario
15.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.12 Saudi Arabia Precision Cancer Diagnostic Test Market Analysis
15.12.1 Precision Cancer Diagnostic Test Has Significantly Revolutionised the Cancer Diagnostic and Treatment Environment in Saudi Arabia
15.12.2 Pre-COVID-19 Market Scenario
15.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.13 Turkey Precision Cancer Diagnostic Test Market Analysis
15.13.1 Pre-COVID-19 Market Scenario
15.13.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.14 UAE Precision Cancer Diagnostic Test Market Analysis
15.14.1 Companies in the UAE Utilising New Collaboration Strategies to Increase Precision Cancer Diagnostic Test
15.14.2 Pre-COVID-19 Market Scenario
15.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.15 Rest of LAMEA Precision Cancer Diagnostic Test Market Analysis
15.15.1 Pre-COVID-19 Market Scenario
15.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16 Company Profiles
16.1 Bio-Rad Laboratories Inc.
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Financial Profile
16.1.4 Company Product Benchmarking
16.1.5 Company Recent Developments
16.2 Illumina Inc
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financial Profile
16.2.4 Company Product Benchmarking
16.2.5 Company Recent Developments
16.3 Biocept Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financial Profile
16.3.4 Company Product Benchmarking
16.3.5 Company Recent Developments
16.4 Epigenomics AG
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Financial Profile
16.4.4 Company Product Benchmarking
16.5 AstraZeneca plc
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Financial Profile
16.5.4 Company Product Benchmarking
16.5.5 Company Recent Developments
16.6 Myriad Genetics Inc.
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Product Benchmarking
16.6.4 Company Recent Developments
16.7 Quest Diagnostics Inc.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Financial Profile
16.7.4 Company Product Benchmarking
16.7.5 Company Recent Developments
16.8 Abbott Laboratories
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Financial Profile
16.8.4 Company Product Benchmarking
16.8.5 Company Recent Developments
16.9 Agilent Technologies Inc.
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Financial Profile
16.9.4 Company Product Benchmarking
16.9.5 Company Recent Developments
16.10 Becton Dickinson and Co.
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Financial Profile
16.10.4 Company Product Benchmarking
16.10.5 Company Recent Developments
17 Conclusion and Recommendations
17.1 Conclusion Summary
17.2 Recommendations
List of Figures
Figure 1 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 2 Global Precision Cancer Diagnostic Test Market Segmentation
Figure 3 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 4 SWOT Analysis
Figure 5 PEST Analysis
Figure 6 Porters Five Forces
Figure 7 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 8 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 9 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 10 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 11 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 12 Global Precision Cancer Diagnostic Test Market Share Forecast by Region 2022, 2027, 2032 (%)
Figure 13 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%))
Figure 14 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 15 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 16 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 17 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 18 Global Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method 2022, 2027, 2032 (%)
Figure 19 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 20 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 21 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 22 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 23 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 24 Global Precision Cancer Diagnostic Test Market Share Forecast by End-User 2022, 2027, 2032 (%)
Figure 25 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 26 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 27 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 28 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 29 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 30 Global Precision Cancer Diagnostic Test Market Share Forecast by Category 2022, 2027, 2032 (%)
Figure 31 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 32 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 33 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 34 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 35 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 36 Global Precision Cancer Diagnostic Test Market Share Forecast by Cancer Type 2022, 2027, 2032 (%)
Figure 37 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 38 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 39 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 40 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 41 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 42 Global Precision Cancer Diagnostic Test Market Share Forecast by Molecular Cancer Testing 2022, 2027, 2032 (%)
Figure 43 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 44 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 45 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 46 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 47 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 48 Global Precision Cancer Diagnostic Test Market Share Forecast by Cancer Imaging Test 2022, 2027, 2032 (%)
Figure 49 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 50 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 51 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 52 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 53 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 54 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 55 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 56 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 57 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 58 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 59 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%))
Figure 60 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (V-Shaped Recovery Scenario)
Figure 61 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (W-Shaped Recovery Scenario)
Figure 62 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (U-Shaped Recovery Scenario)
Figure 63 North America Precision Cancer Diagnostic Test Market by Country,2022-2032 (USD Mn, AGR(%)) (L-Shaped Recovery Scenario)
Figure 64 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 65 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 66 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 67 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 68 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 69 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 70 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 71 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 72 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 73 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 74 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 75 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 76 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 77 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 78 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 79 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 80 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 81 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 82 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 83 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 84 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 85 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 86 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 87 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 88 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 89 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 90 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 91 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 92 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 93 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 94 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 95 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 96 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 97 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 98 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 99 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 100 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 101 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 102 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 103 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 104 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 105 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 106 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 107 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 108 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 109 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 110 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 111 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 112 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 113 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 114 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 115 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 116 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 117 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 118 Europe Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 119 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 120 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 121 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 122 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 123 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 124 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 125 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 126 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 127 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 128 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 129 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 130 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 131 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 132 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 133 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 134 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 135 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 136 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 137 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 138 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 139 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 140 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 141 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 142 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 143 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 144 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 145 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 146 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 147 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 148 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 149 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 150 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 151 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 152 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 153 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 154 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 155 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 156 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 157 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 158 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 159 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 160 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 161 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 162 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 163 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 164 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 165 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 166 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 167 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 168 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 169 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 170 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 171 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 172 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 173 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 174 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 175 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 176 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 177 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 178 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 179 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 180 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 181 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 182 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 183 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 184 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 185 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 186 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 187 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 188 Asia-Pacific Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 189 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 190 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 191 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 192 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 193 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 194 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 195 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 196 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 197 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 198 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 199 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 200 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 201 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 202 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 203 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 204 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 205 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 206 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 207 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 208 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 209 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 210 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 211 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 212 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 213 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 214 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 215 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 216 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 217 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 218 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 219 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 220 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 221 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 222 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 223 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 224 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 225 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 226 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 227 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 228 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 229 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 230 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 231 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 232 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 233 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 234 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 235 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 236 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 237 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 238 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 239 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 240 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 241 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 242 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 243 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 244 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 245 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 246 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 247 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 248 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 249 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 250 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 251 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 252 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 253 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 254 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 255 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 256 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 257 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 258 LAMEA Precision Cancer Diagnostic Test Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 259 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%))
Figure 260 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 261 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 262 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 263 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 264 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%))
Figure 265 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 266 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 267 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 268 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 269 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%))
Figure 270 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 271 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 272 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 273 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 274 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%))
Figure 275 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 276 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 277 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 278 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 279 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%))
Figure 280 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 281 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 282 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 283 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 284 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%))
Figure 285 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 286 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 287 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 288 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 289 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 290 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 291 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 292 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 293 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 294 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 295 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 296 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 297 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 298 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 299 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 300 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 301 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 302 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 303 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 304 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 305 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 306 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 307 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 308 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 309 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 310 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 311 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 312 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 313 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 314 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 315 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 316 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 317 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 318 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 319 Bio-Rad Laboratories Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 320 Bio-Rad Laboratories Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 321 Bio-Rad Laboratories Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 322 Illumina Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 323 Illumina Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 324 Illumina Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 325 Biocept Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 326 Biocept Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 327 Biocept Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 328 Epigenomics AG: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 329 Epigenomics AG: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 330 Epigenomics AG: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 331 AstraZeneca Plc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 332 AstraZeneca Plc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 333 AstraZeneca Plc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 334 Quest Diagnostics Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 335 Quest Diagnostics Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 336 Abbott Laboratories: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 337 Abbott Laboratories: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 338 Abbott Laboratories: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 339 Agilent Technologies Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 340 Agilent Technologies Inc: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 341 Agilent Technologies Inc: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
Figure 342 Becton Dickinson and Co: Company Revenue 2017-2021 (US$ Mn, AGR %)
Figure 343 Becton Dickinson and Co: Company Gross Profit 2017-2021 (US$ Mn, AGR %)
Figure 344 Becton Dickinson and Co: Company Research & Development Expenses 2017-2021 (US$ Mn, AGR %)
List of Tables
Table 1 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 2 Global Precision Cancer Diagnostic Test Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 3 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 4 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 5 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 6 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 7 Global Precision Cancer Diagnostic Test Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 8 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 9 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 10 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 11 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 12 Global Precision Cancer Diagnostic Test Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 13 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 14 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 15 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 16 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 17 Global Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 18 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 19 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 20 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 21 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 22 Global Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 23 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 24 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 25 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 26 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 27 Global Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 28 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 29 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 30 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 31 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 32 Global Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 33 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 34 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 35 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 36 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 37 Global Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 38 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 39 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 40 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 41 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 42 Global Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 43 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 44 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 45 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 46 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 47 North America Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 48 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 49 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 50 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 51 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 52 North America Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 53 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 54 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 55 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 56 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 57 North America Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 58 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 59 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 60 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 61 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 62 North America Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 63 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 64 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 65 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 66 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 67 North America Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 68 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 69 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 70 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 71 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 72 North America Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 73 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 74 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 75 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 76 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 77 North America Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 78 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 79 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 80 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 81 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 82 US Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 83 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 84 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 85 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 86 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 87 Canada Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 88 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 89 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 90 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 91 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 92 Mexico Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 93 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 94 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 95 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 96 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 97 Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 98 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 99 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 100 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 101 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 102 Europe Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 103 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 104 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 105 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 106 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 107 Europe Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 108 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 109 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 110 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 111 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 112 Europe Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 113 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 114 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 115 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 116 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 117 Europe Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 118 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 119 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 120 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 121 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 122 Europe Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 123 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 124 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 125 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 126 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 127 Europe Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 128 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 129 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 130 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 131 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 132 Germany Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 133 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 134 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 135 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 136 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 137 UK Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 138 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 139 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 140 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 141 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 142 France Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 143 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 144 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 145 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 146 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 147 Italy Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 148 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 149 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 150 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 151 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 152 Spain Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 153 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 154 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 155 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 156 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 157 Rest of Europe Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 158 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 159 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 160 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 161 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 162 Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 163 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 164 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 165 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 166 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 167 Asia-Pacific Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 168 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 169 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 170 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 171 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 172 Asia-Pacific Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 173 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 174 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 175 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 176 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 177 Asia-Pacific Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 178 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 179 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 180 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 181 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 182 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 183 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 184 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 185 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 186 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 187 Asia-Pacific Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 188 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 189 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 190 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 191 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 192 Asia-Pacific Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 193 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 194 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 195 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 196 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 197 China Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 198 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 199 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 200 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 201 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 202 India Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 203 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 204 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 205 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 206 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 207 Japan Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 208 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 209 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 210 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 211 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 212 South Korea Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 213 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 214 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 215 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 216 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 217 Australia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 218 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 219 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 220 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 221 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 222 Rest of Asia-Pacific Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 223 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 224 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 225 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 226 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 227 LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 228 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 229 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 230 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 231 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 232 LAMEA Precision Cancer Diagnostic Test Market by Biopsy Method, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 233 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 234 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 235 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 236 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 237 LAMEA Precision Cancer Diagnostic Test Market by End-User, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 238 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 239 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 240 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 241 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 242 LAMEA Precision Cancer Diagnostic Test Market by Category, 2022-2032 (USD Mn, AGR (%), CAGR (%))) (L-Shaped Recovery Scenario)
Table 243 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 244 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 245 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 246 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 247 LAMEA Precision Cancer Diagnostic Test Market by Cancer Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 248 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 249 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 250 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 251 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 252 LAMEA Precision Cancer Diagnostic Test Market by Molecular Cancer Testing, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 253 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 254 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 255 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 256 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 257 LAMEA Precision Cancer Diagnostic Test Market by Cancer Imaging Test, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 258 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 259 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 260 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 261 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 262 Brazil Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 263 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 264 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 265 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 266 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 267 South Africa Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 268 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 269 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 270 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 271 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 272 Saudi Arabia Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 273 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 274 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 275 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 276 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 277 Turkey Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 278 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 279 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 280 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 281 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 282 UAE Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 283 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 284 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 285 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 286 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 287 Rest of LAMEA Precision Cancer Diagnostic Test Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 288 Bio-Rad Laboratories Inc.: Company Information
Table 289 Bio-Rad Laboratories Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 290 Bio-Rad Laboratories Inc.: Company Product and Service Benchmarking
Table 291 Bio-Rad Laboratories Inc: Company Recent Developments
Table 292 Illumina Inc.: Company Information
Table 293 Illumina Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 294 Illumina Inc.: Company Product and Service Benchmarking
Table 295 Illumina Inc: Company Recent Developments
Table 296 Biocept Inc.: Company Information
Table 297 Biocept Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 298 Biocept Inc.: Company Product and Service Benchmarking
Table 299 Biocept Inc: Company Recent Developments
Table 300 Epigenomics A.: Company Information
Table 301 Epigenomics AG: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 302 Epigenomics AG.: Company Product and Service Benchmarking
Table 303 AstraZeneca Plc.: Company Information
Table 304 AstraZeneca Plc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 305 AstraZeneca Plc.: Company Product and Service Benchmarking
Table 306 AstraZeneca Plc: Company Recent Developments
Table 307 Myriad Genetics Inc.: Company Information
Table 308 Myriad Genetics Inc.: Company Product and Service Benchmarking
Table 309 Myriad Genetics Inc: Company Recent Developments
Table 310 Quest Diagnostics Inc.: Company Information
Table 311 Quest Diagnostics Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 312 Quest Diagnostics Inc.: Company Product and Service Benchmarking
Table 313 Quest Diagnostics Inc: Company Recent Developments
Table 314 Abbott Laboratories.: Company Information
Table 315 Abbott Laboratories: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 316 Abbott Laboratories.: Company Product and Service Benchmarking
Table 317 Abbott Laboratories: Company Recent Developments
Table 318 Agilent Technologies Inc.: Company Information
Table 319 Agilent Technologies Inc: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 320 Agilent Technologies Inc: Company Product and Service Benchmarking
Table 321 Agilent Technologies Inc: Company Recent Developments
Table 322 Becton Dickinson and Co.: Company Information
Table 323 Becton Dickinson and Co: Company Revenue 2017-2021 (US$ Mn, AGR %)
Table 324 Becton Dickinson and Co.: Company Product and Service Benchmarking
Table 325 Becton Dickinson and Co: Company Recent Developments
List of Companies Profiled in the report
Abbott Laboratories (Abbott)
Agilent Technologies, Inc.
AstraZeneca PLC (AstraZeneca)
Becton, Dickinson and Firm (BD)
Biocept, Inc.
Bio-Rad Laboratories Inc.
Epigenomics AG
Illumina, Inc. (Illumina)
Myriad Genetics, Inc. (Myriad)
Quest Diagnostics Incorporated
List of Other Companies Mentioned in the report
Abbvie
Abz-Pharma GmbH
Accord Healthcare Ltd
Alexion Pharmaceuticals Inc
Amgen
Apotex Europe Bv
AstraZeneca
Berlex Inc
Biocon
Biogen Inc
BioPartners GmbH
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Celltech, UCB.
Celltrion Healthcare Hungary Kft.
Centocor Ortho Biotech Products LP
Chugai Pharmaceutical Co., Ltd
Coherus Biosciences
Dyax Corp.
Genmab A/S
Genzyme Corp.
Guardant Health
Hexal Ag
Hospira UK Limited
Janssen Biotech Inc
Kyowa Hakko Kirin
Medarex
Medice Arzneimittel Putter GmbH & Co. Kg
MedImmune
Merck
Millennium Pharmaceuticals Inc
MSD
Mylan
Novartis
NovImmmune
Pfizer
Qiagen
Ratiopharm GmbH
Ratiopharm GmbH
Regeneron Pharmaceuticals
Roche
Samsung Bioepis
Sandoz GmbH
Sanofi
Stada Arzneimittel Ag
Sysmex Inostics
Taimed Biologics
Teva GmbH
United Therapeutics Corporation
Wyeth Pharmaceuticals
List of Associations Mentioned in the Report
American Cancer Society
Angeles Clinic and Research Institute
British Columbia Cancer Agency
Cancer Research Institute
Croatian government
Department of Anatomic Pathology and the Department of Medical Oncology
Drug Controller General of India
European Medicines Agency
European Union
Food and Drug Administration
Government of Romania
Hospital Clínic
Institut Gustave Roussy (Villejuif, France)
National Cancer Institute (NCI)
Netherlands Cancer Institute (Amsterdam)
Organization for Economic Co-operation and Development
Serbian government
Spanish National Cancer Research Center (CNIO)
The Christie Hospital (NHS Foundation Trust)
The Cyclotron Centre Bronowice (CCB)
The National Institutes of Health
The Paula Stradinja University Hospital
United Nations
University of Leeds in the United Kingdom
University of Texas Southwestern Medical Center
World Health Organization
Abbott Laboratories (Abbott)
Agilent Technologies, Inc.
AstraZeneca PLC (AstraZeneca)
Becton, Dickinson and Firm (BD)
Biocept, Inc.
Bio-Rad Laboratories Inc.
Epigenomics AG
Illumina, Inc. (Illumina)
Myriad Genetics, Inc. (Myriad)
Quest Diagnostics Incorporated
List of Other Companies Mentioned in the report
Abbvie
Abz-Pharma GmbH
Accord Healthcare Ltd
Alexion Pharmaceuticals Inc
Amgen
Apotex Europe Bv
AstraZeneca
Berlex Inc
Biocon
Biogen Inc
BioPartners GmbH
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Celltech, UCB.
Celltrion Healthcare Hungary Kft.
Centocor Ortho Biotech Products LP
Chugai Pharmaceutical Co., Ltd
Coherus Biosciences
Dyax Corp.
Genmab A/S
Genzyme Corp.
Guardant Health
Hexal Ag
Hospira UK Limited
Janssen Biotech Inc
Kyowa Hakko Kirin
Medarex
Medice Arzneimittel Putter GmbH & Co. Kg
MedImmune
Merck
Millennium Pharmaceuticals Inc
MSD
Mylan
Novartis
NovImmmune
Pfizer
Qiagen
Ratiopharm GmbH
Ratiopharm GmbH
Regeneron Pharmaceuticals
Roche
Samsung Bioepis
Sandoz GmbH
Sanofi
Stada Arzneimittel Ag
Sysmex Inostics
Taimed Biologics
Teva GmbH
United Therapeutics Corporation
Wyeth Pharmaceuticals
List of Associations Mentioned in the Report
American Cancer Society
Angeles Clinic and Research Institute
British Columbia Cancer Agency
Cancer Research Institute
Croatian government
Department of Anatomic Pathology and the Department of Medical Oncology
Drug Controller General of India
European Medicines Agency
European Union
Food and Drug Administration
Government of Romania
Hospital Clínic
Institut Gustave Roussy (Villejuif, France)
National Cancer Institute (NCI)
Netherlands Cancer Institute (Amsterdam)
Organization for Economic Co-operation and Development
Serbian government
Spanish National Cancer Research Center (CNIO)
The Christie Hospital (NHS Foundation Trust)
The Cyclotron Centre Bronowice (CCB)
The National Institutes of Health
The Paula Stradinja University Hospital
United Nations
University of Leeds in the United Kingdom
University of Texas Southwestern Medical Center
World Health Organization
Download sample pages
Complete the form below to download your free sample pages for Precision Cancer Diagnostic Test Market Report 2022-2032Related reports
Cancer Biologics Therapies Market Report 2021-2031
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or...Full DetailsPublished: 01 April 2021Precision Medicine Market Report 2022-2032
The global precision medicine market was valued at US$63,333 million in 2021 and is projected to grow at a CAGR...Full DetailsPublished: 05 July 2022Molecular Diagnostics (MDx) Market Report 2022-2032
The global molecular diagnostics market was valued at US$23,498.2 million in 2022 and is projected to grow at a CAGR...Full DetailsPublished: 01 September 2022Biopharmaceuticals Contract Manufacturing Market Report 2020-2030
As of 2019, the global biopharmaceuticals market’s size was estimated at ~$232 billion. It is expected to grow at a...
Full DetailsPublished: 04 March 2020Point of Care Diagnostics Market Report 2021-2031
Rise in prevalence of target condition has led to increase in adoption of PoC diagnostic in clinics, hospitals and even...Full DetailsPublished: 02 March 2021Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030
Visiongain assesses that the clinical research organizations (CROs) market will generate revenues of $38.0 billion in 2020.
...Full DetailsPublished: 12 February 2020CAR-T Therapy Market Report 2022-2032
The CAR-T Therapy market was valued at US$1.9 billion in 2021 and is projected to grow at a CAGR of...Full DetailsPublished: 02 November 2022Point of Care Diagnostics Market Report 2023-2033
The global Point of Care Diagnostics market is projected to grow at a CAGR of 8.8% by 2033....Full DetailsPublished: 03 January 2023Infectious Disease Diagnostics Market Report 2022-2032
The global Infectious Disease Diagnostics market is projected to grow at a CAGR of 6.61% by 2032....Full DetailsPublished: 16 December 2022Companion Diagnostics (CDx) Market Report 2021-2031
Over the last few years, companion diagnostics has gained widespread attention due to the technological advancements, growing demand for precision...Full DetailsPublished: 07 June 2021
Download sample pages
Complete the form below to download your free sample pages for Precision Cancer Diagnostic Test Market Report 2022-2032Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
20 March 2023
Visiongain Publishes eClinical Solutions Market Report 2023-2033
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
17 March 2023
Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
15 March 2023
Visiongain Publishes Regenerative Medicine Market Report 2023-2033
The global Regenerative Medicine market was valued at US$ 50.37 billion in 2022 and is projected to grow at a CAGR of 18.40% during the forecast period 2023-2033.
10 March 2023
